Response Biomedical Corp.

05/21/2026

¿Podemos diagnosticar antes la insuficiencia cardíaca?

En muchos casos, la IC se detecta tarde… y eso impacta directamente en el pronóstico del paciente.
En este webinar descubrirás cómo los biomarcadores cardíacos pueden ayudarte a cambiar esta realidad en tu práctica diaria.

Hablaremos de:
• Cuándo sospechar IC
• Cómo usar péptidos natriuréticos
• Interpretación práctica de resultados
• Errores comunes que debes evitar
https://buff.ly/V8PPkUT

05/19/2026

It's officially the unofficial start of summer in BC! Happy Victoria Day, everyone. Here's to sunshine, good company, and the long weekend we've been waiting for.

05/15/2026

We're looking for participants to join a one-time research study that takes just 30 minutes of your time. In return, you'll receive a $25 gift card as a thank-you! https://buff.ly/ZfiBcfU

What’s Involved:
• One-time visit to a designated location for a blood draw
• Approximately 30 minutes of your time
• Two 4 mL samples of blood will be collected

05/09/2026

During Heart Failure Week Canada, we recognize the importance of early diagnosis and timely risk assessment in supporting better patient outcomes. RAMP® NT-proBNP is an FDA-cleared whole blood assay designed to aid in the diagnosis and risk stratification of patients with heart failure.
-proBNP

05/08/2026

Heart failure affects hundreds of thousands of Canadians and reinforces the importance of timely diagnosis, monitoring, and patient care. During Heart Failure Awareness Week, we’re sharing this recent research article from the European Heart Journal highlighting important developments and insights in heart failure and cardiovascular care.

https://buff.ly/SlW4kq9

05/08/2026

More than 800,000 Canadians are living with heart failure, with approximately 100,000 new diagnoses each year. Risk factors such as high blood pressure, coronary artery disease, diabetes, obesity, and smoking can all increase the likelihood of developing heart failure.
During Heart Failure Awareness Week Canada, Response Biomedical recognizes the importance of awareness, early diagnosis, and timely clinical decision-making in supporting better patient outcomes.
🔗 Learn more about Heart Failure Awareness Week and available resources: https://lnkd.in/gB5pVDFF

05/07/2026

Heart Failure Awareness Week continues to shine a spotlight on the importance of education, early detection, and improved care for the more than 800,000 Canadians living with heart failure.
At Response Biomedical, we recognize the critical role of timely diagnostics in supporting clinicians and improving patient outcomes. Together, through awareness, innovation, and collaboration, we can continue advancing heart failure care.
🔗 Learn more at heartfailure.ca

04/16/2026

At Response Biomedical, we’re proud to support the lab community with diagnostics that deliver reliable answers when they matter most.

Thank you to all the lab professionals who make a difference—today and every day.

04/07/2026

At Response Biomedical, we are committed to delivering accessible diagnostics across key areas of patient care worldwide.

03/31/2026

Rapid and reliable testing can support faster clinical decisions. The RAMP® D-Dimer test provides quantitative results from EDTA whole blood in approximately 15 minutes, supporting clinicians in assessing thrombotic risk at the point of care.
Learn more:
https://responsebio.com/ramp-tests/cardiovascular/ramp-d-dimer-test/

Are you looking for a D-dimer test for your Lab, RAMP D-dimer test, is a whole blood immunoassay test, that delivers lab results